MWNA
CANO

Marshall Wace North America’s Cano Health, Inc. CANO Stock Holding History

Marshall Wace North America’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,845
Closed -$2.23M – 1799
2021
Q2 		$2.23M Buy
+1,845
New +$2.49M 0.01% 773

Other funds holding CANO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TP
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Marshall Wace North America's CANO Position: Q3 2021 in Review

Marshall Wace North America sold out of Cano Health, Inc. (CANO) in Q3 2021, closing a stake of 1,845 shares — an estimated $2.23M sold.

Marshall Wace North America first reported a position in CANO in Q2 2021 and held it in 1 quarter. The position peaked at $2.23M in Q2 2021. 110 funds tracked by Wall St. Rank hold CANO as of Q3 2021.

  • Marshall Wace North America reported no remaining Cano Health, Inc. position as of Q3 2021 after selling out during the quarter.
  • Marshall Wace North America sold 1,845 Cano Health, Inc. shares in Q3 2021, an estimated $2.23M.
  • Marshall Wace North America first reported a position in Cano Health, Inc. in Q2 2021 and held it in 1 quarter.
  • Marshall Wace North America's Cano Health, Inc. position peaked at $2.23M in Q2 2021.
  • 110 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.